The Medicines Patent Pool – not C-TAP – is the missed opportunity for covid vaccines
A scheme premised on a rejection of the legitimacy of IP during a pandemic was never going to get the buy-in necessary to make it work
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe and start reading now
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.